88452967 - AZURITY PHARMACEUTICALS

Information

• Trademark
• 88452967

• Source

• Serial Number

  88452967

• Registration Number

  6206671

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations

• Filing Date

  May 30, 2019
  6 years ago

• Registration Date

  November 24, 2020
  4 years ago

• Transaction Date

  March 20, 2025
  7 months ago

• Status Date

  November 24, 2020
  4 years ago

• Published for Opposition Date

  March 03, 2020
  5 years ago

• Location Date

  October 21, 2020
  5 years ago

• First Use Anywhere Date

  August 31, 2020
  5 years ago

• First Use In Commerce Date

  August 31, 2020
  5 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  DIBLE, IAN

• Attorney Docket Number

  C10472003400

  Attorney Name

  Douglas R. Wolf

  Law Office Assigned Location Code

  M20

• Owners

  • AZURITY PHARMACEUTICALS, INC
  • CUTISPHARMA, INC. (N/K/A AZURITY PHARMACEUTICALS, INC

Case File Statements

• DM0000: The mark consists of a series of generally hexagonal shaded polygons forming a swirl with a shaded circle at the top of the swirl, with the shapes being colored dark orange, orange, yellow, green, turquoise, dark turquoise, light blue, blue, navy, and purple, all to the left of the purple stylized wording "AZURITY" above the turquoise stylized wording "PHARMACEUTICALS".
• GS0051: pharmaceutical preparations sold as a kit for use by pharmacists and physicians in creating compounded hormone replacement medicines, topical anti-inflammatory and ultrasound gels, pain and gastrointestinal disorders treatment medicines, and anti-inflammatory, antimicrobial, and antifungal treatment medicines; medicines for the treatment of cardiovascular diseases and disorders, colitis, muscle spasm, infectious diseases, acid-reflux disease, ulcer disease, and urological disorders; antibiotics; pharmaceutical products for the treatment of pain, thyroid disorders, gastrointestinal disorders, gastroesophageal disorders, inflammation, infections, fungal diseases and disorders, cardiovascular diseases and disorders, colitis, muscle spasm, attention deficit hyperactivity disorders, infectious diseases, acid-reflux disease, ulcer disease, and urological disorders having vancomycin, enalapril, lisinopril, and methotrexate as the active pharmaceutical ingredient; antacids; muscle relaxants; hormone replacement medicines; topical anti-inflammatory and ultrasound gels; pharmaceutical preparation for the treatment of pain, thyroid disorders, gastrointestinal disorders, gastroesophageal disorders, inflammation, infections, fungal diseases and disorders, cardiovascular diseases and disorders, colitis, muscle spasm, attention deficit hyperactivity disorders, infectious diseases, acid-reflux disease, ulcer disease, and urological disorders; pharmaceuticals for use in the treatment of cancer and autoimmune diseases and disorders, and for the treatment and prevention of renal, oncological, inflammatory, gastrointestinal, gastroesophageal, and cardio-vascular diseases and disorders
• CC0000: The color(s) dark orange, orange, yellow, green, turquoise, dark turquoise, light blue, blue, navy, and purple is/are claimed as a feature of the mark.
• DS0000: "PHARMACEUTICALS"

Case File Event Statements

• 6/3/2019 - 6 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 6/14/2019 - 6 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 6/15/2019 - 6 years ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC

• 8/8/2019 - 6 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 8/9/2019 - 6 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 8/9/2019 - 6 years ago

  6 - NON-FINAL ACTION E-MAILED Type: GNRT

• 8/9/2019 - 6 years ago

  7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 1/29/2020 - 5 years ago

  8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 1/29/2020 - 5 years ago

  9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 1/29/2020 - 5 years ago

  10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 1/30/2020 - 5 years ago

  11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 2/12/2020 - 5 years ago

  12 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 3/3/2020 - 5 years ago

  13 - PUBLISHED FOR OPPOSITION Type: PUBO

• 3/3/2020 - 5 years ago

  14 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 4/28/2020 - 5 years ago

  15 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 4/29/2020 - 5 years ago

  16 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN

• 10/6/2020 - 5 years ago

  17 - TEAS STATEMENT OF USE RECEIVED Type: EISU

• 10/6/2020 - 5 years ago

  19 - USE AMENDMENT FILED Type: IUAF

• 10/20/2020 - 5 years ago

  18 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU

• 10/21/2020 - 5 years ago

  20 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC

• 10/21/2020 - 5 years ago

  21 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR

• 10/22/2020 - 5 years ago

  22 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA

• 11/24/2020 - 4 years ago

  23 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 3/19/2025 - 7 months ago

  24 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK